Periodontics and Endodontics
- Prevention, diagnosis, and treatment of dental caries and other diseases of dental hard tissue
- Diagnosis and treatment of periodontal diseases, pulpal and periapical diseases
Our department has been focusing on the treatment of periodontal diseases and the development of new diagnostic and therapeutic procedures for severe periodontitis. We provide professional medical cares aiming at keeping teeth and tooth-supporting tissues healthy for as long as possible.
Department of Periodontics and Endodontics is appointed as a specialist training institution of the Japanese Society of Periodontology and the Japanese Society of Conservative Dentistry.
| Head | Shinya MURAKAMI |
| Vice Head | Masahiro KITAMURA |
| Chief of Outpatient Clinic | Masahide TAKEDACHI |
| Chief of Inpatient Ward | Motozo YAMASHITA |
■Medical cares
1st clinic in the department of Periodontics and Endodontics (Division of Periodontology)
Prevention, diagnosis and treatment of :
- Severe periodontitis
- Aggressive periodontitis
Periodontal initial preparations such as :
- Tooth brushing instruction
- Scaling & root planning or periodontal pocket curettage
- Minor tooth movement
Periodontal tissue surgeries such as :
- Flap operation
- Mucogingival surgery
- Regenerative treatment of periodontal tissue
Supportive periodontal therapies such as :
- Professional mechanical tooth cleaning
2nd clinic in the department of Periodontics and Endodontics
Prevention, diagnosis and treatment of :
- Dental caries and other diseases of dental hard tissue
- Pulpal and periapical diseases and moderate periodontitis
■Development of new periodontal regenerative medicine
We have been investigating the efficacy and the safety of FGF2 (basic fibroblast growth factor) in periodontal treatment. REGROTH®, a treatment that utilizes fibroblast growth factor-2 (FGF-2), has been studied for many years in our hand and was finally approved for production on September 28, 2016 by the Ministry of Health, Labour and Welfare of Japan. This product is the world’s first and only pharmaceutical that includes growth factors developed for the purpose of periodontal regeneration. We have also been investigating the utility of autologous adipose tissue-derived multi-lineage progenitor cells transplantation therapy at the Cell Processing Center in the Center for Translational Dental Research.
